Chiral amines are important for the chemical and pharmaceutical industries, and there is rapidly growing interest to use transaminases for their synthesis. Since the cost of the enzyme is an important factor for process economy, the use of whole-cell biocatalysts is attractive, since expensive purification and immobilization steps can be avoided. Display of the protein on the cell surface provides a possible way to reduce the mass transfer limitations of such biocatalysts. However, transaminases need to dimerize in order to become active, and furthermore, they require the cofactor pyridoxal phosphate; consequently, successful transaminase surface expression has not been reported thus far. In this work, we produced an Arthrobacter citreus -transaminase in Escherichia coli using a surface display vector based on the autotransporter adhesin involved in diffuse adherence (AIDA-I), which has previously been used for display of dimeric proteins. The correct localization of the transaminase in the E. coli outer membrane and its orientation toward the cell exterior were verified. Furthermore, transaminase activity was detected exclusively in the outer membrane protein fraction, showing that successful dimerization had occurred. The transaminase was found to be present in both full-length and proteolytically degraded forms. The removal of this proteolysis is considered to be the main obstacle to achieving sufficient whole-cell transaminase activity.
C
hiral amines are important compounds, both as building blocks for pharmaceuticals and for use in the chemical industry (1, 2) . Since asymmetric chemical synthesis of chiral amines with a high enantioselectivity remains challenging and requires toxic transition metal catalysts, there is a need for alternative synthesis methods (1) (2) (3) . One such alternative approach is the use of -transaminases. Transaminases are enzymes that catalyze the transfer of an amino group from one substrate (the amino donor) to a carboxyl group of the second substrate (the amino acceptor) through the use of the cofactor pyridoxal-5=-phosphate (PLP) (4) . The major advantage of transaminases is the possibility of achieving a high enantioselectivity. Thus, if a prochiral ketone is used as the amino acceptor, the product will be a chiral amine.
A drawback to using transaminases compared to conventional chemical methods is the cost of the enzyme catalyst (5) . Purification of the enzyme is relatively expensive, and reusability of the enzyme is preferred. This requires immobilization of the enzyme, which further adds to the cost (6, 7) . Another approach is the use of whole bacterial cells producing the transaminase, thereby removing the need for enzyme purification. However, the bacterial cell membrane(s) forms a barrier for the diffusion of the substrates into the cell, which slows down or completely prevents the enzymatic reaction (5, 6) . A way to avoid this diffusion barrier is to utilize surface expression technology (7) .
Surface expression is the fusion of the protein of interest, in this case a transaminase, to a natural surface protein of the host cell. This results in the recombinant protein being transported to and subsequently displayed on the surface of the host. Several techniques are available for this purpose, and the type Va autotransporter pathway of pathogenic Gram-negative bacteria is an example where the mechanism has been described in some detail (8) . This pathway has been successfully transferred into nonpathogenic laboratory strains and used to display a range of recombinant proteins. Autotransporters are synthesized as single peptides containing all the main components necessary for their translocation to the cell surface. They consist of three main parts: an N-terminal signal peptide targeting the protein for transport to the periplasm via the Sec system, a passenger protein that is exposed on the cell surface, and a C-terminal ␤-barrel that anchors the protein in the outer cell membrane and forms a pore for the translocation of the passenger. The present understanding of the mechanism has been extensively reviewed elsewhere (8, 9) . The adhesin involved in diffuse adherence (AIDA-I) of enteropathogenic Escherichia coli (10) is one of the most frequently used autotransporters for recombinant surface expression, and its use has previously been reported for display of enzymes (11) , enzyme inhibitors (12) , and vaccine epitopes (13) .
An obstacle for successful surface expression of transaminases is the requirement for the enzyme to be a dimer in order to be active. This relies on two separate monomers being in close proximity on the cell surface, which has previously been reported for other recombinant passengers using autotransporters (14, 15) . In addition, the transaminase must be present in a sufficiently high concentration to promote this dimerization (16) .
In the present study, we report the surface expression of an -transaminase variant from Arthrobacter citreus. Transaminases are difficult proteins from a surface expression point of view due to several factors. (i) They are dependent on cofactors, requiring pyridoxal-5=-phosphate for activity. (ii) They are active only in dimeric forms, meaning that dimerization must occur on the cell surface. (iii) They are relatively large proteins (the transaminase used in the present investigation is 53 kDa), which is commonly problematic in surface expression. The results presented here are a first step toward obtaining a whole-cell biocatalyst for transamination based on surface expression in a Gram-negative bacterium.
MATERIALS AND METHODS
Strains, plasmids, and cultivation media. Plasmid pET28aϩ containing the gene for an Arthrobacter citreus -transaminase variant (AcTA) (17) was used for intracellular production of transaminase, as well as the template for amplification of the transaminase gene. The pAIDA1 plasmid (18) was used for surface expression of the transaminase. This plasmid carries genes encoding the signal peptide and ␤-barrel (AIDA c ) of AIDA-I, with a cloning site for a recombinant passenger protein between the genes. To enable detection of the recombinant passenger, the cloning site is flanked by two detection tags: an N-terminal His 6 tag located outside the recombinant passenger relative to the cell membrane and a C-terminal Myc epitope tag (19) (Fig. 1) .
The host organism for surface expression was an OmpT-negative strain derived from E. coli K-12 0:17 (20) (0:17⌬OmpT), which has previously been found suitable for recombinant surface expression using the AIDA autotransporter (13, 18, 21) . E. coli strain BL21(DE3) was used for production of purified transaminase using the T7-based promoter of pET28aϩ. All surface expression experiments were performed in a minimal salts medium (21) with 10 g liter Ϫ1 glucose as the carbon source, while production of purified transaminase was performed using lysogeny broth (LB) medium. Cultures of cells containing pAIDA1 derivatives were supplemented with chloramphenicol (10 g ml Ϫ1 ), and cultures of E. coli BL21 containing the pET28aϩ-based vector were supplemented with kanamycin (40 g ml Ϫ1 ). Cloning. The pAIDA1 plasmid was digested using KpnI and SacI. The gene for AcTA was PCR amplified from the pET28aϩ plasmid, and the amplified gene was digested with KpnI and SacI and ligated into the vector. The resulting circular plasmid was transformed into E. coli 0:17⌬OmpT using heat shock (22) . Successful transformants were selected using chloramphenicol-containing LB agar plates and verified by sequencing (Eurofins MWG Operon).
Production of purified transaminase. E. coli BL21 harboring the pET28aϩ plasmid with AcTA was cultivated overnight in 25 ml LB medium, diluted into 500 ml fresh LB medium, and placed at 37°C. The culture was induced by isopropyl-␤-D-1-thiogalactopyranoside (IPTG) to a final concentration of 400 M. The cells were allowed to produce the product for 24 h followed by cell harvest using centrifugation (2,500 rpm, 15 min, 4°C). The resulting cell pellet was dissolved in immobilized metal ion affinity chromatography (IMAC) binding buffer (20 mM Na 2 HPO 4 , 0.5 M NaCl [pH 7.4]), and the cells were lysed at 8.0 ϫ 10 7 Pa using a French press high-pressure homogenizer (SLM Aminco). The cell lysate was clarified through centrifugation (25,000 rpm, 4°C, 1 h), followed by filtration through a 0.2-m membrane filter. The clarified homogenate was purified by IMAC using the ÄKTA Explorer chromatography system (Amersham Pharmacia). The column was washed with binding buffer, and the transaminase was eluted from the column using IMAC elution buffer (20 mM Na 2 HPO 4 , 0.5 M NaCl, 0.5 M imidazole [pH 7.4]). Finally, a PD10 desalting column (GE Healthcare) was used for buffer exchange into a suitable storage buffer, and the purified transaminase was lyophilized. The purity of the final enzyme preparation was evaluated using SDS-PAGE (not shown).
Cultivation of E. coli for surface expression of transaminase. E. coli strain 0:17⌬OmpT with the pAIDA1-AcTA plasmid was inoculated from a glycerol stock into a shake flask containing 25 ml of minimal medium. The bacteria were allowed to grow overnight in a shake incubator (37°C, 180 rpm). The following morning the exponentially growing culture was reinoculated into 500 ml of fresh medium to a final optical density at 600 nm (OD 600 ) of 0.1. IPTG was added to a final concentration of 200 M when the culture reached an OD of 0.2 in order to induce the transaminase production. The culture was induced for 4 h, followed by cell harvest using centrifugation (2,500 rpm, 4°C, 15 min). The harvested cells were washed using transaminase activity buffer (50 mM phosphate, The AIDA c pore is integrated into the outer membrane, allowing the translocation and exposure of the passenger. The His 6 detection tag is located outside the passenger relative to the cell membrane, while the Myc tag is located inside the passenger. The linker region acts as a spacer between the passenger and the cell membrane. The transaminase passenger dimerizes on the cell surface and catalyzes the transamination reaction. The transaminase is represented by a crystal structure of Chromobacterium violaceum -transaminase (PDB accession no. 4A6R [25] ). 0.9% [wt/vol] NaCl [pH 7.0]) and centrifuged a second time, followed by measurement of the transaminase activity of the whole cells.
Analyses. (i) Cell growth. Microbial growth was monitored by periodically withdrawing cell suspension samples from the shake flasks followed by measuring OD 600 using a spectrophotometer (Novaspec II; Pharmacia). All samples were diluted to an OD 600 of approximately 0.1 prior to measurement in order to avoid effects of the linear range of OD 600 measurements. True OD 600 values were obtained by multiplying the measured OD 600 with the dilution factor.
(ii) Flow cytometric analysis. Samples of cell suspensions for analysis of surface expression were withdrawn periodically from growing cultures. The withdrawn samples were diluted to an OD 600 of approximately 2 before they were mixed with equal volumes of sterile 50% (vol/vol) glycerol. After the samples were mixed with glycerol, they were frozen and stored at Ϫ80°C until the time of analysis. The stability of surface expression levels during storage using this method has previously been verified (21) . On the day of analysis, 50 l of each sample was washed with 800 l phosphate-buffered saline (PBS) (9.0 g liter Ϫ1 NaCl, 0.21 g liter Ϫ1 KH 2 PO 4 , 0.73 g liter Ϫ1 Na 2 HPO 4 [pH 7.4]) and centrifuged (4,500 rpm, 10 min, 4°C). The resulting pellet was dissolved in 100 l PBS containing 10 g ml Ϫ1 each of THE His tag antibody conjugated to fluorescein isothiocyanate (FITC) (GenScript) and anti-c-Myc antibody conjugated to SureLight allophycocyanin (AbCam). The samples were incubated at room temperature with end-over-end mixing for 1 h covered with tin foil. After incubation, the samples were once more pelleted and then washed with 100 l PBS as described above. Finally, the pellets were dissolved in 500 l ice-cold PBS and analyzed using a Gallios flow cytometer (Beckman Coulter) using the FL1 and FL6 detectors. The fluorescence levels were compared with a negative control (strain 0:17⌬OmpT without the expression plasmid) and a positive control consisting of the pAIDA1 vector without any recombinant passenger.
(iii) Outer membrane protein isolation and Western blot analysis. Cells expressing pAIDA1-AcTA were harvested through centrifugation (1,200 ϫ g, 15 min, 4°C), and 1.6 g of the resulting pellets was collected. Cellular protein from these pellets were fractionated into soluble, inner membrane (IM), and outer membrane (OM) protein fractions as previously described (21) . The protein fractions were mixed 3:1 with 4ϫ reducing SDS loading dye, and 10 l of each sample was electrophoretically separated using 10% SDS-polyacrylamide gels (NuPAGE Bis-Tris; Invitrogen). The separated proteins were transferred onto polyvinylidene difluoride (PVDF) membranes using a semidry Western blotting machine (Bio-Rad). After the proteins were transferred, the membranes were blocked for 1 h in PBS containing 5% (wt/vol) nonfat milk powder (Semper). After the membranes were blocked, they were washed for 5 min in PBS containing 0.5 ml liter Ϫ1 Tween 20 (PBST). The washed membranes were incubated for 1 h in PBST containing 1 g liter Ϫ1 bovine serum albumin (BSA) and 0.5 g ml Ϫ1 antibody. The antibodies used were THE His tag (conjugated to horseradish peroxidase [HRP]) or THE cMyc tag (conjugated to HRP) (GenScript). Nonbound antibodies were removed by washing the membranes with PBST four times (for 5 to 10 min each time). Finally, the membranes were developed using the Amersham ECL Prime Western blotting reagent (GE Healthcare), and after 5 min of incubation, the chemiluminescence was recorded on a Molecular Imager ChemiDoc XRSϩ system (Bio-Rad).
(iv) Transaminase activity. Whole cells and the purified protein fractions were assayed for the presence of active transaminase. Cell suspensions were harvested by centrifugation (1,200 ϫ g, 15 min, 4°C) at the end of cultivation. The resulting pellets were washed using phosphate buffer (50 mM sodium phosphate, 0.9% [wt/vol] NaCl [pH 7.0]) and centrifuged once more. Finally, the pellets were dissolved in phosphate buffer to an approximate OD 600 of 50.
Transaminase activity was monitored through the reaction between (S)-substituted aminotetraline (Cambrex) and pyruvate (Sigma), resulting in the formation of L-alanine and tetralone. This assay enabled visual detection due to brown color formation by spontaneous oxidation of the tetralone product. The reaction buffer consisted of 100 mM sodium pyruvate, 50 mM substituted aminotetraline, and 0.1 mM PLP in phosphate buffer (50 mM sodium phosphate, 0.9% [wt/vol] NaCl [pH 7.0]). Portions (50 l each) of whole-cell suspension and the respective protein fractions were mixed with the reaction buffer to a final volume of 200 l and added to 96-well microtiter plates. The plates were then covered with plastic film and incubated with shaking (37°C, 180 rpm) until color development could be observed.
RESULTS
Transaminase expression. The transaminase was successfully cloned into the surface expression vector pAIDA1, and the resulting vector was named pAIDA1-AcTA. E. coli 0:17⌬OmpT containing the plasmid was grown in minimal medium containing glucose and induced with isopropyl-␤-D-1-thiogalactopyranoside (IPTG) to produce the fusion protein. Cellular protein from the cultivation was separated into soluble, inner membrane (IM), and outer membrane (OM) fractions in order to verify the correct expression of the AIDA c -AcTA fusion protein. Western blot analysis was performed on these cellular fractions and developed using antibodies against the N-terminal His 6 tag. A single band appeared in the OM fraction at the expected size of the fusion protein, while no significant bands were visible in either the soluble or IM protein fraction (Fig. 2) , confirming the presence of the transaminase in the desired cellular compartment.
Transaminase activity. Regardless of the correct expression, there is a second obstacle for obtaining activity: dimerization of the transaminase. The transaminase is a homodimer in its active form; thus, two separate, correctly folded transaminase-AIDA c fusions must be in close proximity to form an active dimer. Furthermore, the transaminase dimer must be oriented toward the outside to be accessible for the substrates and the PLP cofactor. Having verified the presence of the transaminase in the OM, we thus proceeded to explore the transaminase activity of the cells. Transaminase activity can be measured by a fast colorimetric assay with aminotetraline and pyruvate as the substrates, where the formed tetralone product spontaneously oxidizes, leading to the development of a brown color. Whole cells producing the transaminase and samples of the soluble, IM, and OM protein fractions were incubated in a reaction buffer containing these substrates. Purified transaminase was used as a reference. A strong brown color formed in wells containing the purified transaminase, confirming that the assay can detect the presence of active enzyme (Fig. 3) . As expected, the reaction could be detected in the OM protein fraction, and no activity was detected in the soluble and IM protein fractions. This confirms that all active transaminase was located in the outer membrane fraction, in accordance with the findings from the Western blot analysis. However, analysis of the whole-cell fraction did not show any detectable color development.
Orientation of surface-expressed AcTA. Since the outer membrane showed transaminase activity, while the intact cells did not, we proceeded to test whether the transaminase was correctly displayed on the cell surface. By labeling cells producing the transaminase with fluorescent antibodies toward both the His 6 and Myc tags, it is possible to detect the presence and localization of these peptides that flank the passenger. The labeled cells were analyzed using flow cytometry, and the fluorescence histograms for the two tags were recorded. A clear shift in fluorescence compared to that of the negative control (mean fluorescence of 5.47 versus 0.55) was obtained from the signal based on the Myc tag antibody, and the signal was stronger than that of the positive control (3.10). On the other hand, only a weak signal could be seen from the His 6 tag antibody (0.87 versus 40.8 for the positive control) (Fig. 4) . The Myc tag fluorescence shows that the transaminase was transported to the outer membrane and at least partially translocated to the cell surface. However, a stronger fluorescence from the His 6 tag would be expected if all transaminase proteins on the cell surface were present at its full length.
Two hypotheses regarding the low His 6 tag signal on the cell surface were formulated. (i) The transaminase was present as a full-length protein but was not fully translocated through the AIDA c pore, exposing the Myc tag but leaving the N-terminal His 6 tag facing the periplasmic side (thus being undetectable by flow cytometry). (ii) The transaminase was proteolytically cleaved during the OM transition to the cell surface. Both these possibilities would explain the reduced fluorescence of the N-terminal His 6 tag compared to the Myc tag levels, as well as the low transaminase activity of the intact cells. Western blot analysis using the C-terminal Myc tag was used to test the second hypothesis. Soluble, IM, and OM protein fractions were blotted and probed using an antiMyc antibody. Several bands ranging from full length down to a length approximately the size of the AIDA c translocator appeared on the blot (Fig. 5) . This confirmed that the transaminase had been subjected to proteolysis and was present in several partially degraded forms, as well as full-length protein. Since these degraded forms could be visualized only when Myc tag antibodies were used and not when the His 6 tag antibodies were used (Fig. 2) , it could be concluded that they resulted from proteolysis in the N-terminal part of the passenger protein. This result strongly supports the results from the flow cytometric analysis, and it could be concluded that the weak His 6 tag signal obtained on the flow cytometer was due to loss of the detection tag.
DISCUSSION
Our aim in this study was to engineer E. coli to display an -transaminase on the cell surface, which could further be used as a whole-cell biocatalyst for production of chiral amines. The autotransporter-transaminase fusion protein was successfully produced and incorporated into the outer membrane of the bacterial cell at the full length of the fusion protein, as shown from Western blot and flow cytometry data. In addition, several proteolytically degraded forms of the transaminase were found.
Transaminase activity was detected in the outer membrane fraction of the cell, while the intact cells were negative. Insufficient transaminase dimerization on the cell surface is the most likely explanation for this. It has previously been shown that proteins displayed using autotransporters may form dimers on the cell surface (14, 15) . The proposed mechanism for this relies on a free diffusion of the autotransporter ␤-barrel in the outer membrane, enabling passenger dimerization when two monomers encounter each other (Fig. 1B) . However, this diffusion is restricted to the two-dimensional plane of the membrane in the intact cell. In a solution, the diffusion of the monomers would be less restricted, which could explain the presence of active transaminase in the purified OM protein fraction but not in the intact cell.
Since the protein was present only in the outer membrane, it can be concluded that the observed proteolytic degradation occurred after transport to the periplasm, due to the requirement of an intact N-terminal signal peptide for secretion. Therefore, proteolysis occurs either during transit through the periplasm, during surface translocation, or at the cell surface. We previously expressed the synthetic protein Z derived from Staphylococcus aureus protein A (21) and the Salmonella proteins SefA and H:gm (13, 21) and observed similar proteolysis patterns. Together with the results in the present study, we observe that larger recombinant passenger proteins appear more susceptible to proteolysis. The smaller proteins Z (6.6 kDa) and SefA (14.4 kDa) were readily expressed, while the larger H:gm (53 kDa) and the present transaminase (53.2 kDa per monomer) were both subjected to proteolysis. Furthermore, a small subunit of H:gm (H:gmd) was found to be readily expressed on the cell surface without being degraded. Together, these indicate a correlation between passenger size and surface expression levels (23) . We propose that the comparatively slow periplasmic processing of larger proteins, leading to longer residence times in an unfolded conformation, radically increases the susceptibility to proteolytic degradation. A premature folding of large proteins in the periplasm may also be a likely fate and may lead to undetectable N termini, since these folded proteins will be incapable of translocation through the narrow autotransporter pore (8) . This trapping may also subject the transaminase to periplasmic proteolysis. Independent of the underlying mechanism, the observed degradation of only the N-terminal part is in accordance with a passenger translocation mechanism where the C-terminal part passes through the AIDA c pore first with the N-terminal part following in a hair-pin conformation (24) , since this would leave the N-terminal part exposed in the periplasm until the whole protein is translocated.
Transaminases are a difficult class of enzymes from a surface expression point of view due to their relatively large size, the requirement of dimerization for activity, and the need for the cofactor PLP. Nevertheless, we show the expression of active forms of the studied transaminase exclusively in the correct cellular fraction, showing the potential for this technology for use in wholecell transamination processes. Further optimization is needed to achieve whole cells with sufficient transaminase activity, and it is recommended that this optimization should primarily be focused on minimizing proteolysis of the transaminase passenger.
